Sanitizexperts: fighting COVID-19 with automated robots
While the global COVID-19 pandemic has impacted every industry sector globally, it has also demonstrated how innovative digital technologies can be used more effectively.
Take, for example, Dubai-based Sanitizexperts, which develops and engineers advanced industrial air sanitisation solutions.
The company has announced the introduction of its Automated UVC Robot, an intelligent innovation designed to disinfect public spaces.
Rather than existing systems that often use harmful chemicals, sprays and smells and can leave residue, the new robot will provide safe 360-degree disinfection.
The innovation is the result of extensive testing specifically to find solutions that combat COVID-19 by the International Ultraviolet Association (IUVA).
This has found that UV disinfection technologies can offer a multiple barrier approach to reducing the transmission of COVID-19 virus.
Sanitizexperts’ UV and sterilisation robot uses intelligent pulse disinfection and nature navigation AI technology to automatically plan its path and judge the disinfection time required within a specific environment.
It uses radar vision and ultrasonic obstacle avoidance in order to move freely around a space without collision.
The robot uses UV lamps to fight the virus. These can work up to 8,000 hours, disinfect and kill effectively and safely.
The robot is also able to recognise when a human is within reach, upon which it automatically shuts the lamp.
According to Sanitizexperts, the robot works through wifi and can be managed with the click of a button either on a PC or through the app.
The software assists users in mapping the area that needs sanitising - it is possible to have multiple automated UVC robots working simultaneously.
When battery level energy is low, the robot automatically returns to its station and charges
Omar Chappuis, CEO of Sanitizexperts explained: “Whether in a hospital, airport, mall, home or the office, the robot will ensure that bacteria are eliminated, allowing for clean, safe living.”
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”